dc.contributor.author | Barciela, Paula | |
dc.contributor.author | Perez-Vazquez, Ana | |
dc.contributor.author | Mansour, Sepidar | |
dc.contributor.author | Donn, Pauline | |
dc.contributor.author | Garcia-Perez, P. | |
dc.contributor.author | Carpena, Maria | |
dc.contributor.author | Fraga-Corral, Maria | |
dc.contributor.author | Simal-Gandara, Jesus | |
dc.contributor.author | Prieto Lage, Miguel A. | |
dc.date.accessioned | 2025-01-30T11:46:51Z | |
dc.date.available | 2025-01-30T11:46:51Z | |
dc.date.issued | 2024 | |
dc.description.abstract | Currently, consumers are more conscious about the importance of having a good diet and lifestyle; so the demand for products with potential health benefits has increased. Nutraceuticals can be classified according to different criteria. Based on their chemical structure, they can be divided into phenolic compounds, fatty acids and structural lipids, carbohydrates and amino-acids derivatives, minerals, and terpenoids derivatives. All these compounds are linked to different health benefits, such as antioxidant, anticancer and anti-inflammatory activity, prevention of neurodegenerative and cardiovascular diseases, or health bones maintenance. However, the potential positive impact of these compounds when incorporated in the human body is limited because of their bioavailability, which is mainly affected because of the hydrophobic properties of these compounds. In this way, different delivery systems were developed as suitable pathways for the bioavailability improvement of nutraceuticals. The most successful delivery systems to incorporate nutraceuticals include micro and nanoemulsions, micelles, nanoparticles, hydrogels, and solid-lipid nanoparticles. They achieved several improvements such as higher bioavailability, bioactivity maintenance, shelf-life improvement, or incorporation of the nutraceutical in a target system/organ. In this way, and considering the increasing demand for these products, the development of regulation is needed so that consumers' safety is assured, although any country has developed it yet. Thus, considering the increasing demand for these compounds, the aim of this study was to compile the available current data of nutraceuticals and also their safety concerns. © 2024 Walter de Gruyter GmbH, Berlin/Boston. All rights reserved. | pt_PT |
dc.description.sponsorship | The research leading to these results was supported by MICINN supporting the Ramón y Cajal grant for M.A. Prieto (RYC-2017-22,891); by Xunta de Galicia for supporting the program EXCELENCIA-ED431F 2020/12, the post-doctoral grant of M. Fraga-Corral (ED481B-2019/096), and the pre-doctoral grant of M. Carpena (ED481A 2021/313). Authors are grateful to Ibero-American Program on Science and Technology (CYTED - AQUA-CIBUS, P317RT0003), and to the Bio Based Industries Joint Undertaking (JU) under grant agreement No 888003 UPHEALTH Project (H2020-BBI-JTI-2019). The UJ receives support from the European Union's Horizon 2020 research and innovation program and the Bio Based Industries Consortium. The project SYSTEMIC Knowledge hub on Nutrition and Food Security, has received funding from national research funding parties ni Belgium (FWO), France (INRA), Germany (BLE), Italy (MIPAAF), Latvia (IZM), Norway (RCN), Portugal (FCT), and Spain (AEL) in a joint action of JPI HDHL, JPI- OCEANS and FACCE-JPI launched in 2019 under the ERA-NET ERA-HDHL (n° 696295). | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Barciela, Paula; Perez-Vazquez, Ana; Mansour, Sepidar; Donn, Pauline; Garcia-Perez, P.; Carpena, Maria; Fraga-Corral, Maria; Simal-Gandara, Jesus; Prieto Lage, Miguel A. (2024). Toxicity and safety of nutraceuticals. In Nutraceuticals: A Holistic Approach to Disease Prevention. Berlin: Walter de Gruyter, p. 345-364. ISBN 978-311131760-1 | pt_PT |
dc.identifier.doi | 10.1515/9783111317601-016 | pt_PT |
dc.identifier.isbn | 978-311131760-1 | |
dc.identifier.uri | http://hdl.handle.net/10198/31102 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Walter de Gruyter | pt_PT |
dc.relation | Sustainable and cost-effective production process for the upcycling of olive, grape and nut by-products into 4 natural and healthy ingredients for nutraceutical and cosmetic applications | |
dc.relation | ERA-NET Biomarkers for Nutrition and Health implementing the JPI HDHL objectives | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
dc.subject | Fatty acids | pt_PT |
dc.subject | Lipids | pt_PT |
dc.subject | Nanoparticles | pt_PT |
dc.subject | Neurodegenerative diseases | pt_PT |
dc.title | Toxicity and safety of nutraceuticals | pt_PT |
dc.type | book part | |
dspace.entity.type | Publication | |
oaire.awardTitle | Sustainable and cost-effective production process for the upcycling of olive, grape and nut by-products into 4 natural and healthy ingredients for nutraceutical and cosmetic applications | |
oaire.awardTitle | ERA-NET Biomarkers for Nutrition and Health implementing the JPI HDHL objectives | |
oaire.awardURI | info:eu-repo/grantAgreement/EC/H2020/888003/EU | |
oaire.awardURI | info:eu-repo/grantAgreement/EC/H2020/696295/EU | |
oaire.citation.endPage | 364 | pt_PT |
oaire.citation.startPage | 345 | pt_PT |
oaire.citation.title | Nutraceuticals: A Holistic Approach to Disease Prevention | pt_PT |
oaire.fundingStream | H2020 | |
oaire.fundingStream | H2020 | |
person.familyName | Fraga-Corral | |
person.familyName | Prieto Lage | |
person.givenName | Maria | |
person.givenName | Miguel A. | |
person.identifier | 1054547 | |
person.identifier | 107688 | |
person.identifier.ciencia-id | 1616-98AD-4546 | |
person.identifier.ciencia-id | 221E-1E00-AB74 | |
person.identifier.orcid | 0000-0002-5663-9239 | |
person.identifier.orcid | 0000-0002-3513-0054 | |
person.identifier.rid | G-7335-2017 | |
person.identifier.rid | G-4516-2011 | |
person.identifier.scopus-author-id | 56346469200 | |
person.identifier.scopus-author-id | 35937495700 | |
project.funder.identifier | http://doi.org/10.13039/501100008530 | |
project.funder.identifier | http://doi.org/10.13039/501100008530 | |
project.funder.name | European Commission | |
project.funder.name | European Commission | |
rcaap.rights | restrictedAccess | pt_PT |
rcaap.type | bookPart | pt_PT |
relation.isAuthorOfPublication | 446f0a90-be7c-4111-9949-42475fda0e6a | |
relation.isAuthorOfPublication | 13260615-fd28-4b8b-9dd4-8a8466007579 | |
relation.isAuthorOfPublication.latestForDiscovery | 13260615-fd28-4b8b-9dd4-8a8466007579 | |
relation.isProjectOfPublication | 9980c0d6-0317-49a0-a44d-b8aedf2294a5 | |
relation.isProjectOfPublication | 160ee2e3-b63a-4185-ac5d-5deb7281fef2 | |
relation.isProjectOfPublication.latestForDiscovery | 160ee2e3-b63a-4185-ac5d-5deb7281fef2 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- 2024.04_Toxicity and safety of nutraceuticals.PDF
- Size:
- 2.24 MB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.75 KB
- Format:
- Item-specific license agreed upon to submission
- Description: